Sanjit O. Tewari

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma”.

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00597

N/A

1.7DataRank · unranked

58 citations

R. Eric Davis, Lei Feng, Fredrick B. Hagemeister, Raphaël Steiner, Hun Ju Lee +24 more

ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV

Blood Advances(2023)10.1182/bloodadvances.2022009622

N/A

0DataRank · unranked

7 citations

Oren Pasvolsky, Lei Feng, Guofan Xu, Sanjit O. Tewari, Jaimole Varghese +9 more

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-208300

N/A

0DataRank · unranked

0 citations

Naishu Kui, Ryan Sun, Eslam Aboismail, Sanjit O. Tewari, Ajlan Al Zaki +26 more